Congenital heart disease and acquired valvular lesions in pregnancy;Angeborene herzfehler und erworbene herzklappenfehler in der schwangerschaft

Herz

Volumn 28, Issue 3, 2003, Pages 227-239

  Horstkotte, Dieter ^a   Faßbender, Dieter ^b   Piper, Cornelia ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b NONE

Author keywords

Acquired valvular lesions; Anticoagulation regimens; Congenital heart disease; Endocarditis; Hypertrophic cardiomyopathy; Pregnancy

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; CEPHALOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLUCLOXACILLIN; HEPARIN; IMIPENEM; LOW MOLECULAR WEIGHT HEPARIN; MACROLIDE; PENICILLIN DERIVATIVE; PHENPROCOUMON; RIFAMPICIN; VANCOMYCIN;

ANTICOAGULATION; AORTA COARCTATION; AORTA DISSECTING ANEURYSM; ARTICLE; BACTERIAL ENDOCARDITIS; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CONGESTIVE HEART FAILURE; CYANOSIS; EMBRYOTOXICITY; FALLOT TETRALOGY; FEMALE; FETOTOXICITY; FETUS HYPOXIA; GERMANY; HEART ARRHYTHMIA; HEART ATRIUM SEPTUM DEFECT; HEART FUNCTION; HEART OUTPUT; HEART RATE; HEART STROKE VOLUME; HEART VENTRICLE SEPTUM DEFECT; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; LUNG VASCULAR RESISTANCE; MITRAL VALVE STENOSIS; OSTEOPOROSIS; PATENT DUCTUS ARTERIOSUS; PHYSICAL ACTIVITY; PREGNANCY; PREGNANCY COMPLICATION; PROGNOSIS; RISK BENEFIT ANALYSIS; STENT; SYSTEMIC VASCULAR RESISTANCE; THROMBOCYTOPENIA; THROMBOEMBOLISM; TRANSLUMINAL VALVULOPLASTY; TREATMENT OUTCOME; VALVULAR HEART DISEASE;

EID: 0038547870     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-003-2467-y     Document Type: Article

References (70)

1. Adam D, Gahl K, Graevenitz A von, Horstkotte D, Kraus F, Lode H, Niebel J, Peters, Ruckdeschel G, Schumacher G, Struck E, Werdan K. Revidierte Empfehlungen zur Prophylaxe bakterieller Endokarditiden. Kommission für klinische Kardiologie der Deutschen Gesellschaft für Kardiologie - Herz- und Kreislaufforschung. Z Kardiol 1998;87:566-8.
2. Al Kasab SM, Sabag T, Al Zaibag M, Awaad M, Al Bitar I, Halim MA, Abdullah MA, Shahed M, Rajendran V, Sawyer W. Beta-adrenergic receptor blockade in the management of pregnant women with mitral stenosis. Am J Obstet Gynecol 1990;163:37-40.
3. Autore C, Conte MR, Piccininno M, et al. Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40:1864-9.
4. Banning AP, Pearson JF, Hall RJ. Role of balloon dilatation of the aortic valve in pregnant patients with severe aortic stenosis. Br Heart J 1993;70:544.
5. Ben Farhat M, Gamra H, Betbout F, Maatouk F, Jarrar M, Addad F, Tiss M, Hammami S, Chahbani I, Thaalbi R. Percutaneous balloon mitral commissurotomy during pregnancy. Heart 1997;77:564-7.
6. Bonow RO, Carabello B, de Leon AC Jr, et al. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 1998;32:1468-588.
7. Branko WM, Otto H. Preoperative cardiovascular evaluation for noncardiac surgery: congenital heart disease and heart disease in pregnancy deserve better guidelines. Circulation 1997; 95:530-1.
8. Calvin SE. Use of vasodilators during pregnancy. In: Elkayam U, Gleicher N, eds. Cardiac problems in pregnancy, 3rd edn. New York: Wiley-Liss, 1998:391-8.
9. Chambers CE, Clark SI. Cardiac surgery during pregnancy. Clin Obstet Gynecol 1994;37:316-23.
10. Chan WS, Anand S, Ginsberg JC. Antikoagulation of pregnant women with mechanical heart valves. A systematic review of the literature. Arch Intern Med 2000;160:191-6.
11. Clapp JF III, Capless E. Cardiovascular function before, during and after the first and subsequent pregnancies. Am J Cardiol 1997;80:1469-73.
12. Clark SI, Cotton DB, Lee W, et al. Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol 1989; 161:1439-42.
13. Clarkson PM, Wilson NJ, Neutze JM, North RA, Calder AL, Barratt-Boyes BG. Outcome of pregnancy after the Mustard operation for transposition of the great arteries with intact ventricular septum. J Am Coll Cardiol 1994;24:190-3.
14. Cohn LH, Collins JJ Jr, Rizzo RJ, Adams DH, Couper GS, Aranki SF. Twenty-year follow-up of the Hancock modified orifice porcine aortic valve. Ann Thorac Surg 1998;66:S30.
15. Connolly HM, Warnes CA. Ebstein's anomaly: outcome of pregnance. J Am Coll Cardiol 1994;23:1194-8.
16. Dashe JS, Gilstrap LC. Antibiotic use in pregnancy. Obstet Gynecol Clin North Am 1997;24:617-29.
17. De Souza JA, Martinez EE Jr, Ambrose JA, Alves CM, Born D, Buffolo E, Carvalho AC. Percutaneous balloon mitral valvuloplasty in comparison with open mitral valve commissurotomy for mitral stenosis during pregnancy. J Am Coll Cardiol 2001;37:900-3.
18. Du ZD, Hijazi ZM, Kleinman CS, Silverman NH, Larntz K. Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults. J Am Coll Cardiol 2002;39:1836-44.
19. Elkayam U. Pregnancy and cardiovascular disease, In: Braunwald E, et al., eds. Heart disease, 6th edn. Philadelphia: Saunders, 2001:2172-91.
20. Elkayam U, Dave R. Hypertrophic cardiomyopathy and pregnancy. In: Elkayam U, Gleicher N, eds. Cardiac problems in pregnancy, 3rd edn. New York: Wiley-Liss 1996:211-21.
21. Elkayam U, Gleicher N. Hemodynamic and cardiac function during normal pregnancy and the puerperium. In: Elkayam U, Gleicher N, eds. Cardiac problems in pregnancy, 3rd edn. New York: Wiley-Liss, 1998:3-20.
22. Faclouach S, Azzouzi L, Tahiri A, Chararbi PV. Aortic coarctation and pregnancy: a propos of 3 cases followed-up during a period of 10 years. Ann Cardiol Angiol 1994;45:262-5.
23. Faßbender D, Seggewiss H, Schmidt HK, et al. Differential diagnose der Mitralklappenstenose. Herz 1998;23:420-8.
24. Gohlke-Bärwolf C. Antikoagulation in graviditate und post partum bei Vitien, Thrombosen oder Vorhofflimmern: fötale Bedrohung versus maternelle Thromboembolie. Z Kardiol 2001; 90:Suppl IV:49-56.
25. Gohlke-Bärwolf C, Acar J, Oakley C, et al. Guidelines for prevention of thromboembolic events in valvular heart disease. Eur Heart J 1995;16:1320-30.
26. Hameed A, Karaalp IS, Tummala PP, Wani OR, Canetti M, Akhter MW, Goodwin I, Zapadinsky N, Elkayam U. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol 2001;37:893-9.
27. Heinonen CP, Slone D, Shapiro S. Birth defects and drugs in pregnancy. Littleton: Littleton Publishing Sciences, 1977.
28. Hering D, Horstkotte D. Einsatz niedermolekularer Heparine bei Kunstklappenträgern. Dtsch Med Wochenschr 2003:im Druck.
29. Herrmann HC, Hill JA, Krol J, Kleaveland JP, Pepine CJ. Effectiveness of percutaneous balloon valvuloplasty in adults with pulmonic valve stenosis. Am J Cardiol 1991;68:1111-3.
30. Horstkotte D, Faßbender D. Angeborene Herzfehler im Erwachsenenalter. In: Paumgartner G, Steinbeck G. Therapie innerer Krankheiten. Berlin: Springer 2003:im Druck.
31. Horstkotte D, Loogen F. Erworbene Herzklappenfehler. München: Urban & Schwarzenberg, 1987.
32. Horstkotte D, Paselk CH, Bircks W, Loogen F. Klinische Langzeitergebnisse nach Korrekturoperation einer Fallotschen Tetralogie. Z Kardiol 1993;82:552-62.
33. Horstkotte D, Piper C, Wiemer M, Schultheiß HP. Management von Patienten mit Aortenklappenstenosen. Herz 1998;23:434-40.
34. Horstkotte D, Schulte HD, Niehues R, et al. Diagnostic and therapeutic considerations in acute severe mitral regurgitation: experience in 42 consecutive patients entering the intensive care unit with pulmonary edema. J Heart Valve Dis 1993;2:512-22.
35. Hunter S. Management of adults with congenital heart disease. Heart 1997;78:15.
36. Jamieson WRE, Miller DC, Akins CW et al. Pregnancy and bioprostheses: influence on structural valve deterioration. Ann Thorac Surg 1995;60:S282-7.
37. Kaemmerer H, Bauer U, Stein JI, Lemp S, Bartmus D, Hoffmann A, Niesert S, Osmers R, Fratz S, Rossa S, Lange PE, Beitzke A, Schneider KT, Hess J. Pregnancy in congenital cardiac an increasing challenge for cardiologists and obstetricians - a prospective multicenter study. Z Kardiol 2003;92:16-23.
38. Köhler F, Fotuhi, G. Baumann: Schwangerschaft und angeborene Herzfehler. Z Kardiol 2001;90:Suppl IV:30-5.
39. Koopman MMW, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996;334:682-7.
40. Lao TT, Sermer M, Colman JM. Pregnancy following surgical correction for transposition of the great arteries. Obstet Gynecol 1994;83:665-8.
41. Levine M, Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996;334:677-81.
42. Lindhoff-Last E, Schinzel H, Erbe M, Schächinger V, Bauersachs R. Antikoagulation in der Schwangerschaft bei mechanischem Herzklappenersatz. Z Kardiol 2001;90:Suppl 6:125-30.
43. Lock JE, Block PC, McKay RG, Baim DS, Keane JF. Transcatheter closure of ventricular septal defects. Circulation 1988;78:361-8.
44. Loebstein R, Lalkin A, Koren G. Pharmacokinetic changes during pregnancy and their clinical relevance. Clin Pharmacokinet 1997;33:328-43.
45. Martens MG. Cephalosporins. Obstet Gynecol Clin North Am 1989;16:291-304.
46. Montalescot G, Polle V, Collet JP, et al. Low molecular weight heparin after mechanical heart valve replacement. Circulation 2000;101:1083-6.
47. Morgan DJ. Drug exposition in mother and fetus. Clin Exp Pharmacol Physiol 1997;24:869-73.
48. Neumayer U, Schmidt HK, Fassbender D, et al. Early (three-month) results of percutaneous mitral valvotomy with the Inoue balloon in 1,123 consecutive patients comparing various age groups. Am J Cardiol 2002;90:190-3.
49. Oakely C. Pregnancy and congenital heart disease. Heart 1997; 78:12-4.
50. Pelliccia F, Cianfrocca C, Gaudio C, Reale A. Sudden death during pregnancy in hypertrophic cardiomyopathy. Eur Heart J 1992;13:421.
51. Pettila V, Leinonen P, Markkola A, Hillesmaa V, Kaaja R. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost 2002;87:182-6.
52. Piper C, Wiemer M, Schultheiss HP, Horstkotte D. Sinnvolle Diagnostik und Therapieplanung bei organischer und relativer Mitralklappeninsuffizienz. Herz 1998;23:429-33.
53. Presbitero P, Somerville J, Stone S, Aruta E, Spiegelhalter D, Rabajoli F. Pregnancy in cyanotic congenital heart disease: outcome of mother and fetus. Circulation 1994;89:2673-6.
54. Reyes MP, Ostrea EM Jr, Cabinian AE, Schmitt C, Rintelmann W. Vancomycin during pregnancy: does it cause hearing loss or nephrotoxicity in the infant? Am J Obstet Gynecol 1989;161:977-81.
55. Roth A, Shotan A, Elkayam U. A randomized comparison between the hemodynamic effects of hydralazine and nitroglycerin alone and in combination at rest and during isometric exercise in patients with chronic mitral regurgitation. Am Heart J 1993;125:155-63.
56. Saidi AS, Bezold LI, Altman CA, Ayres NA, Bricker JT. Outcome of pregnancy following intervention for coarctation of the aorta. Am J Cardiol 1998;82:786-8.
57. Salem DN, Daudelin HD, Levine HJ, Pauker SG, Eckman MH, Riff J. Antithrombotic therapy in valvular heart disease. Chest 2001; 119: Suppl 1:S207-19.
58. Schröder F, Weiss T. Niedermolekulare Heparine. Dtsch Med Wochenschr 2002;127:1645-7.
59. Shotan A, Widerhorn J, Hurst A, Elkayam U. Risks of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use. Am J Med 1994;96:451-6.
60. Sievert H, Ensslen R, Fach A, et al. Transcatheter closure of patent ductus arteriosus with the Rashkind occluder. Eur Heart J 1997;18:1014-8.
61. Siv SC, Sermer M, Harrison DA et al. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation 1997;96:2789-94.
62. Statistisches Bundesamt. Statistisches Jahrbuch 2000 für die Bundesrepublik Deutschland. Stuttgart: Metzler & Pöschel, 2000:71.
63. Thanopoulos BD, Hadjinikolaou L, Konstadopoulou GN, Tsaousis GS, Triposkiadis F, Spirou P. Stent treatment for coarctation of the aorta: intermediate term follow-up and technical considerations. Heart 2000;84:65-70.
64. Unger F, Rainer WG, Horstkotte D, Ghosh P, Rutishauser W, Braunwald E, Duran C, Olin C, Cooley DA, Bodor E, Reichart B, Schistek R, Oppell UV, Ade W, Wada J. Standards and concepts in valve surgery. Thorac Cardiovasc Surg 2000;48:175-82.
65. Warnes CA, Elkayam U. Congenital heart disease and pregnancy. In: Elkayam U, Gleicher N, eds. Cardiac problems in pregnancy, 3rd edn. New York: Wiley-Liss, 1998:39-53.
66. Weiss BM, von Segesser LK, Alon E, Seifert B, Turina MI. Outcome of cardiovascular surgey and pregnance: a systematic review of the period 1984-1996. Am J Obstet Gynecol 1998;179:1643-53.
67. Weiss BM, Maggiorini M, Jenni R, Lauper U, Popov V, Bombeli T, Spahn DR. Pregnant patient with primary pulmonary hypertension: inhaled pulmonary vasodilators and epidural anesthesia for cesarean delivery. Anesthesiology 2000;92:1191-4.
68. Weiss BM, Hess OM. Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives. Eur Heart J 2000;21:104-15.
69. Whittemore R, Wells JA, Castellsague X. A second-generation study of 427 probands with congenital heart defects and their 837 children. J Am Coll Cardiol 1994;23:1459-67.
70. Whittemore R, Hobbins JC, Engle MA. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease. Am J Cardiol 1982;50:641-51.